Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biofeedback vs Aripiprazole for Tic Disorders
NCT05361993Phase 4Withdrawn
- Sponsor
- Children's Hospital of Fudan University
- Start
- Jun 2024
- Primary completion
- Dec 2024
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial (2 arms), sponsored by Children's Hospital of Fudan University. Primary endpoints: Yale Global Tic Severity Scale and Wisconsin Card Sorting Test. Planned start Jun 2024; status: withdrawn.
Beyond the preview
Go deeper on NCT05361993.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05361993.